Unknown EARLY_PHASE1 INTERVENTIONAL 1-arm NCT03381807

Human Amniotic Epithelial Stem Cell in Treatment of Refractory Severe Intrauterine Adhesion

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University

Interventions hAESCs

Updated 7 times since 2018 Last updated: Oct 25, 2020 Started: Sep 16, 2020 Primary completion: Sep 1, 2022 Completion: Sep 1, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This EARLY_PHASE1 trial investigates Intrauterine Adhesion and is currently ongoing. Second Affiliated Hospital, School of Medicine, Zhejiang University leads this study, which shows 7 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown EARLY_PHASE1

Status: Unknown Status → Unknown
Oct 2023 — Jul 2024 [monthly]

Unknown Status EARLY_PHASE1

Status: Recruiting → Unknown Status
Jan 2021 — Oct 2023 [monthly]

Recruiting EARLY_PHASE1
Nov 2020 — Jan 2021 [monthly]

Recruiting EARLY_PHASE1

Status: Not Yet Recruiting → Recruiting

▶ Show 2 earlier versions

Jun 2018 — Nov 2020 [monthly]

Not Yet Recruiting EARLY_PHASE1
Jan 2018 — Jun 2018 [monthly]

Not Yet Recruiting EARLY_PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Second Affiliated Hospital, School of Medicine, Zhejiang University
Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China

Data source: Second Affiliated Hospital, School of Medicine, Zhejiang University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hangzhou, China